{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/peripheral-arterial-disease/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"39825e21-a7b7-573c-86a7-fd5d87a847d3","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 63f833b0-9dbb-4423-853c-7d157a84c0c6 --><h2>Update</h2><!-- end field 63f833b0-9dbb-4423-853c-7d157a84c0c6 -->","summary":null,"htmlStringContent":"<!-- begin item d1b08b09-800d-4aa5-8bff-0a0c6ed0013f --><!-- end item d1b08b09-800d-4aa5-8bff-0a0c6ed0013f -->","topic":{"id":"fff7e03a-2313-5ab5-b744-9c6bba67aa6b","topicId":"deeaf796-d620-42bf-903e-a43ff99b1d1d","topicName":"Peripheral arterial disease","slug":"peripheral-arterial-disease","lastRevised":"Last revised in September 2019","chapters":[{"id":"9e988871-ea98-52a6-bb9d-910e22b3a6dd","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"81e6bfaf-7c78-52e2-b11d-8e2315ebe9e4","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"fee65eb3-86d0-571b-9815-f9407ec29fa7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"239ddbef-73a4-5941-9dc8-52d73689e140","slug":"changes","fullItemName":"Changes"},{"id":"39825e21-a7b7-573c-86a7-fd5d87a847d3","slug":"update","fullItemName":"Update"}]},{"id":"da348d6d-4102-5de5-b9be-d28e7c83e8d0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c0f3f64c-323d-5c10-b5ff-9df793eab0d8","slug":"goals","fullItemName":"Goals"},{"id":"504b7741-50ac-5c4c-ac51-ea56d8cc4c46","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a7e09ccb-6701-5658-a01c-52a02d7f9f80","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a54b63f6-0b42-5584-91e8-027e613f7246","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f6168c43-2e36-5e1d-bb44-04674d098b73","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"67399dd0-adb5-5b36-a616-cfc0605ebe52","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"9c30093e-b7fa-5c0f-84d0-465bf0768823","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8f766fdc-ff98-5227-9d99-fe65802aaaca","slug":"definition","fullItemName":"Definition"},{"id":"4c33be40-568c-527a-8936-a79726b11e66","slug":"causes","fullItemName":"Causes"},{"id":"b8817533-a2e9-531b-9c51-d1c3da17b2ef","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ea6fdfd8-a5f7-52de-ac19-8a05fd53556f","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"cdbbc165-3643-5f50-8f32-9fc5504ba2ef","slug":"complications","fullItemName":"Complications"},{"id":"59787aa9-8de0-5efd-b54e-2d72c75845a5","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"59e978dc-e4bc-574d-a047-413f87ec6b3d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ea4a531c-cf38-5e54-85d9-1f845bf7582f","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"ebe23574-b6e5-5812-816c-6955392cee34","slug":"assessment","fullItemName":"Assessment"},{"id":"c501646c-c9a8-5372-ae9c-c0aab453c6e5","slug":"features-of-acute-limb-ischaemia","fullItemName":"Features of acute limb ischaemia"},{"id":"fdc33cb6-26a1-58c3-8eab-79d69745d871","slug":"features-of-intermittent-claudication-critical-limb-ischaemia","fullItemName":"Features of intermittent claudication and critical limb ischaemia"},{"id":"8c98aa45-6aef-5b47-a997-e9eeec827356","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"04fcdfca-c3cb-56b4-a18e-535c5a54e1a9","fullItemName":"Management","slug":"management","subChapters":[{"id":"fb3fcf0a-56a8-5693-b5ef-75e12c6f1f11","slug":"acute-limb-ischaemia","fullItemName":"Scenario: Acute limb ischaemia"},{"id":"d89d9e21-f892-533e-a3b8-e5649a205398","slug":"critical-limb-ischaemia","fullItemName":"Scenario: Critical limb ischaemia"},{"id":"357ee79f-9fa4-57e7-abd7-7881201f1629","slug":"intermittent-claudication","fullItemName":"Scenario: Intermittent claudication"}]},{"id":"da28584d-59b4-5a06-9357-9484a9bf93cc","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"e3ab00c1-43b9-58c7-a1c4-44198627e4ab","slug":"naftidrofuryl-oxalate","fullItemName":"Naftidrofuryl oxalate"},{"id":"bb79b6c3-de22-58b3-9244-5ae82a6133ad","slug":"paracetamol-weak-opioids","fullItemName":"Paracetamol and weak opioids"}]},{"id":"1545d985-832b-5a4a-abc9-bd7f0c21b754","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"049d6682-f78d-5c05-bdfb-1dbd5e91b017","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"58d7e6c5-f97f-507d-b627-87ab85bde479","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"574b8e96-33b9-5191-81dd-f415c704abf9","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f3df8039-73c2-5c30-b7e8-2566977e32dc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d466274b-a2ab-58f1-badc-abfed7066e4f","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"aaed3513-3a59-5991-8410-2c4446539abd","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"74346084-c291-5a06-ac3d-a0ae85243940","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"fee65eb3-86d0-571b-9815-f9407ec29fa7","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"49e55c5e-622d-51a1-8b84-c731b4a26943","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 2f5afd10-7ef6-4ee6-8fe4-c2061643c831 --><h3>New evidence</h3><!-- end field 2f5afd10-7ef6-4ee6-8fe4-c2061643c831 -->","summary":null,"htmlStringContent":"<!-- begin item b3cdc9fc-68e8-435d-976b-056739210b0f --><!-- begin field b114d62d-0a99-4a37-811c-73e5fad3c162 --><h3>Evidence-based guidelines</h3><!-- end field b114d62d-0a99-4a37-811c-73e5fad3c162 --><!-- begin field e5b99b7b-2a63-4745-a6c6-ba0e88d7ba18 --><p>No new evidence-based guidelines since 1 July 2019.</p><!-- end field e5b99b7b-2a63-4745-a6c6-ba0e88d7ba18 --><!-- begin field ac82ab35-b02f-4ad2-ab52-b15817d8248b --><h3>HTAs (Health Technology Assessments)</h3><!-- end field ac82ab35-b02f-4ad2-ab52-b15817d8248b --><!-- begin field ddd7ab9a-dfde-4e2c-964f-ba477c79af74 --><p>No new HTAs since 1 July 2019.</p><!-- end field ddd7ab9a-dfde-4e2c-964f-ba477c79af74 --><!-- begin field 020ce99d-0586-4547-97ff-8f5fbc548952 --><h3>Economic appraisals</h3><!-- end field 020ce99d-0586-4547-97ff-8f5fbc548952 --><!-- begin field 803f8b38-e79b-4a87-84be-c80007fd6180 --><p>No new economic appraisals relevant to England since 1 July 2019.</p><!-- end field 803f8b38-e79b-4a87-84be-c80007fd6180 --><!-- begin field e79fdcff-bf13-4334-b5ba-d6c3f12be610 --><h3>Systematic reviews and meta-analyses</h3><!-- end field e79fdcff-bf13-4334-b5ba-d6c3f12be610 --><!-- begin field 75d65e2a-1be3-4680-8611-502c6790d76d --><p>No new systematic reviews since 1 July 2019.</p><!-- end field 75d65e2a-1be3-4680-8611-502c6790d76d --><!-- begin field b8df5473-d52f-4eda-993d-6ca2aa012204 --><h3>Primary evidence</h3><!-- end field b8df5473-d52f-4eda-993d-6ca2aa012204 --><!-- begin field 2f0bf2c5-dbc1-4a46-8c5f-b5bbaa411be5 --><p>No new randomized controlled trials published in the major journals since 1 July 2019.</p><!-- end field 2f0bf2c5-dbc1-4a46-8c5f-b5bbaa411be5 --><!-- end item b3cdc9fc-68e8-435d-976b-056739210b0f -->","subChapters":[]},{"id":"f0a2161c-5983-5d17-8b49-af8d3893ebbe","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field a2c90c78-6a8a-404b-98bb-59daf90b3d71 --><h3>New policies</h3><!-- end field a2c90c78-6a8a-404b-98bb-59daf90b3d71 -->","summary":null,"htmlStringContent":"<!-- begin item dc2783c6-5337-4f6f-be5d-5164b9a8f2f0 --><!-- begin field e1b7d313-3330-4a72-884c-7b4223cb0966 --><p>No new national policies or guidelines since 1 July 2019.</p><!-- end field e1b7d313-3330-4a72-884c-7b4223cb0966 --><!-- end item dc2783c6-5337-4f6f-be5d-5164b9a8f2f0 -->","subChapters":[]},{"id":"cc985ba5-ea8f-53c5-9193-203f4fe58c90","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field ee9cc26b-eb35-4aa9-8a9f-93e0953e0374 --><h3>New safety alerts</h3><!-- end field ee9cc26b-eb35-4aa9-8a9f-93e0953e0374 -->","summary":null,"htmlStringContent":"<!-- begin item 2b2b728e-0dcd-405e-b9ad-1e810ffc1896 --><!-- begin field 59557f90-c611-4508-a4a6-c7a982b01a9a --><p>No new safety alerts since 1 July 2019.</p><!-- end field 59557f90-c611-4508-a4a6-c7a982b01a9a --><!-- end item 2b2b728e-0dcd-405e-b9ad-1e810ffc1896 -->","subChapters":[]},{"id":"2c81a350-84e4-5dc6-9539-af6f9cb1c262","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 92f0bb53-6508-42a6-9163-98fb7a87b8df --><h3>Changes in product availability</h3><!-- end field 92f0bb53-6508-42a6-9163-98fb7a87b8df -->","summary":null,"htmlStringContent":"<!-- begin item 16683cd9-d7d4-44fa-8f24-ea6e15e681d6 --><!-- begin field 393c566e-2259-4370-8000-d4aafa3127b0 --><p>No changes in product availability since 1 July 2019.</p><!-- end field 393c566e-2259-4370-8000-d4aafa3127b0 --><!-- end item 16683cd9-d7d4-44fa-8f24-ea6e15e681d6 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}